Publication: 127

Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B trial 9430
      QxMD      Google Scholar   
Citation:
J Thorac Oncol vol 3 (11) 1301-1307
Year:
2008
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA047577, U10 CA032291, CA33601, U10 CA031946-25, U10 CA077658, U10 CA033601-26, U10 CA031946-19, U10 CA033601-23, U10 CA031946-23, U10 CA031946, U10 CA033601, U10 CA033601-22, U10 CA033601-21, U10 CA033601-27, U10 CA031946-22, U10 CA077440, U10 CA033601-20, U10 CA041287, U10 CA047559, U10 CA031946-24, U10 CA033601-25, U10 CA031946-21, U10 CA031946-18, U10 CA031946-20, U10 CA047642, U10 CA033601-24, CA31946, U10 CA003927  
Corr. Author:
 
Authors:
               
Networks:
 
Study
CALGB-9430
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
CALGB, paclitaxel, chemotherapy, lung cancer, small cell lung cancer